Global Haemophilia Epidemiology and Patient Flow Analysis - 2016

  • ID: 3514430
  • Report
  • Region: Global
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The author announced the results of its Haemophilia patient population study in a new report ‘Global Haemophilia Epidemiology and Patient Flow Analysis - 2016’. The report provides insights into Haemophilia epidemiology, Haemophilia diagnosed patients, and Haemophilia treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Haemophilia derived from epidemiological analysis, percentage of patients diagnosed with Haemophilia, and percentage of patients treated with Haemophilia therapy.

The study helps executives estimate Haemophilia market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Haemophilia prevalence, Haemophilia diagnosis rate, and Haemophilia treatment rate for the period 2015 - 2022. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Features of the Report:
- Haemophilia: Disease Definition
- Haemophilia Patient Flow
- Haemophilia Prevalence
- Haemophilia Diagnosed Patients
- Haemophilia Treated Patients

This report will take 1-2 business days to deliver.
Note: Product cover images may vary from those shown
2 of 3
1. Haemophilia: Disease Definition
2. Global Haemophilia Patient Flow
2A. Global Haemophilia Prevalence
2B. Global Haemophilia Diagnosed Patients
2C. Global Haemophilia Treated Patients
3. Haemophilia Patient Flow in the US
3A. Haemophilia Prevalence in the US
3B. Haemophilia Diagnosed Patients in the US
3C. Haemophilia Treated Patients in the US
4. Haemophilia Patient Flow in Europe
4A. Haemophilia Prevalence in Europe
4B. Haemophilia Diagnosed Patients in Europe
4C. Haemophilia Treated Patients in Europe
5. Haemophilia Patient Flow in Germany
5A. Haemophilia Prevalence in Germany
5B. Haemophilia Diagnosed Patients in Germany
5C. Haemophilia Treated Patients in Germany
6. Haemophilia Patient Flow in France
6A. Haemophilia Prevalence in France
6B. Haemophilia Diagnosed Patients in France
6C. Haemophilia Treated Patients in France
7. Haemophilia Patient Flow in Spain
7A. Haemophilia Prevalence in Spain
7B. Haemophilia Diagnosed Patients in Spain
7C. Haemophilia Treated Patients in Spain
8. Haemophilia Patient Flow in Italy
8A. Haemophilia Prevalence in Italy
8B. Haemophilia Diagnosed Patients in Italy
8C. Haemophilia Treated Patients in Italy
9. Haemophilia Patient Flow in UK
9A. Haemophilia Prevalence in UK
9B. Haemophilia Diagnosed Patients in UK
9C. Haemophilia Treated Patients in UK
10. Haemophilia Patient Flow in Japan
10A. Haemophilia Prevalence in Japan
10B. Haemophilia Diagnosed Patients in Japan
10C. Haemophilia Treated Patients in Japan
11. Appendix
12. Research Methodology
12A. Sources

Table 1: Global Haemophilia Patient Flow (2015)
Table 2: Global Haemophilia Patient Flow Forecast (2015 - 2022)
Table 3: Haemophilia Patient Flow in the US (2015)
Table 4: Haemophilia Patient Flow Forecast in the US (2015 - 2022)
Table 5: Haemophilia Patient Flow in Europe (2015)
Table 6: Haemophilia Patient Flow Forecast in Europe (2015 - 2022)
Table 7: Haemophilia Patient Flow in Germany (2015)
Table 8: Haemophilia Patient Flow Forecast in Germany (2015 - 2022)
Table 9: Haemophilia Patient Flow in France (2015)
Table 10: Haemophilia Patient Flow Forecast in France (2015 - 2022)
Table 11: Haemophilia Patient Flow in Spain (2015)
Table 12: Haemophilia Patient Flow Forecast in Spain (2015 - 2022)
Table 13: Haemophilia Patient Flow in Italy (2015)
Table 14: Haemophilia Patient Flow Forecast in Italy (2015 - 2022)
Table 15: Haemophilia Patient Flow in UK (2015)
Table 16: Haemophilia Patient Flow Forecast in UK (2015 - 2022)
Table 17: Haemophilia Patient Flow in Japan (2015)
Table 18: Haemophilia Patient Flow Forecast in Japan (2015 - 2022)

Figure 1: Global Haemophilia Patient Flow (2015)
Figure 2: Global Haemophilia Patient Flow Forecast (2015 - 2022)
Figure 3: Haemophilia Patient Flow in the US (2015)
Figure 4: Haemophilia Patient Flow Forecast in the US (2015 - 2022)
Figure 5: Haemophilia Patient Flow in Europe (2015)
Figure 6: Haemophilia Patient Flow Forecast in Europe (2015 - 2022)
Figure 7: Haemophilia Patient Flow in Germany (2015)
Figure 8: Haemophilia Patient Flow Forecast in Germany (2015 - 2022)
Figure 9: Haemophilia Patient Flow in France (2015)
Figure 10: Haemophilia Patient Flow Forecast in France (2015 - 2022)
Figure 11: Haemophilia Patient Flow in Spain (2015)
Figure 12: Haemophilia Patient Flow Forecast in Spain (2015 - 2022)
Figure 13: Haemophilia Patient Flow in Italy (2015)
Figure 14: Haemophilia Patient Flow Forecast in Italy (2015 - 2022)
Figure 15: Haemophilia Patient Flow in UK (2015)
Figure 16: Haemophilia Patient Flow Forecast in UK (2015 - 2022)
Figure 17: Haemophilia Patient Flow in Japan (2015)
Figure 18: Haemophilia Patient Flow Forecast in Japan (2015 - 2022)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll